94 related articles for article (PubMed ID: 26343951)
1. Anti-angiogenic collagen fragment arresten is increased from 16 weeks' gestation in pre-eclamptic plasma.
Yong HE; Murthi P; Wong MH; Kalionis B; Brennecke SP; Keogh RJ
Placenta; 2015 Nov; 36(11):1300-9. PubMed ID: 26343951
[TBL] [Abstract][Full Text] [Related]
2. Increased decidual mRNA expression levels of candidate maternal pre-eclampsia susceptibility genes are associated with clinical severity.
Yong HE; Murthi P; Borg A; Kalionis B; Moses EK; Brennecke SP; Keogh RJ
Placenta; 2014 Feb; 35(2):117-24. PubMed ID: 24331737
[TBL] [Abstract][Full Text] [Related]
3. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
4. Malondialdehyde and antioxidant enzymes in second and third trimesters of pre-eclamptic Nigerian women.
Atiba AS; Abbiyesuku FM; Adekanle DA; Oparinde DP; Ajose OA; Niran-Atiba TA
Niger Postgrad Med J; 2014 Jun; 21(2):150-4. PubMed ID: 25126869
[TBL] [Abstract][Full Text] [Related]
5. Maternal hemoglobin at 27-29 weeks' gestation and severity of pre-eclampsia.
Cordina M; Bhatti S; Fernandez M; Syngelaki A; Nicolaides KH; Kametas NA
J Matern Fetal Neonatal Med; 2015 Sep; 28(13):1575-80. PubMed ID: 25184521
[TBL] [Abstract][Full Text] [Related]
6. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome.
Cetković A; Miljic D; Ljubić A; Patterson M; Ghatei M; Stamenković J; Nikolic-Djurovic M; Pekic S; Doknic M; Glišić A; Bloom S; Popovic V
Endocr Res; 2012; 37(2):78-88. PubMed ID: 22489921
[TBL] [Abstract][Full Text] [Related]
7. Second and third trimester serum levels of HtrA1 in pregnancies affected by pre-eclampsia.
Skinner S; Rolnik DL; Wang Y; Nie G; Syngelaki A; Nicolaides KH; da Silva Costa F
Placenta; 2021 Mar; 106():1-6. PubMed ID: 33601219
[TBL] [Abstract][Full Text] [Related]
8. Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Wright D; Silva M; Papadopoulos S; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jul; 46(1):42-50. PubMed ID: 25847022
[TBL] [Abstract][Full Text] [Related]
9. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy.
Yie SM; Taylor RN; Librach C
Am J Obstet Gynecol; 2005 Jul; 193(1):204-8. PubMed ID: 16021080
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester.
Deveci K; Sogut E; Evliyaoglu O; Duras N
J Obstet Gynaecol Res; 2009 Feb; 35(1):94-8. PubMed ID: 19215554
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone.
Kosicka K; Siemiątkowska A; Krzyścin M; Bręborowicz GH; Resztak M; Majchrzak-Celińska A; Chuchracki M; Główka FK
PLoS One; 2015; 10(12):e0144343. PubMed ID: 26637176
[TBL] [Abstract][Full Text] [Related]
12. Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia.
Santos LL; Wertaschnigg D; Rolnik DL; Da Silva Costa F; Syngelaki A; Dimitriadis E; Nicolaides KH
Placenta; 2021 Jan; 103():76-81. PubMed ID: 33099202
[TBL] [Abstract][Full Text] [Related]
13. Free radical attack on membrane lipid and antioxidant vitamins in the course of pre-eclamptic pregnancy.
Atiba AS; Abbiyesuku FM; 'Niran-atiba TA; Oparinde DP; Ajose OA; Akindele RA
Ethiop J Health Sci; 2014 Jan; 24(1):35-42. PubMed ID: 24591797
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats.
Sugiyama A; Mitsui A; Okada M; Yamawaki H
J Vet Med Sci; 2019 Apr; 81(4):522-531. PubMed ID: 30726795
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Feb; 45(2):190-8. PubMed ID: 25296530
[TBL] [Abstract][Full Text] [Related]
16. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy.
Hentschke MR; Lucas LS; Mistry HD; Pinheiro da Costa BE; Poli-de-Figueiredo CE
Cytokine; 2015 Jul; 74(1):152-6. PubMed ID: 25957465
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin B and urotensin II levels in pre-eclampsia.
Liu Y; Li Y; Xu X; Chen X; Chen H
J Matern Fetal Neonatal Med; 2010 Aug; 23(8):869-73. PubMed ID: 20017703
[TBL] [Abstract][Full Text] [Related]
18. Serum free β-human chorionic gonadotropin in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Wright D; Papadopoulos S; Silva M; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jul; 46(1):51-9. PubMed ID: 25846870
[TBL] [Abstract][Full Text] [Related]
19. Association of maternal serum high sensitive C-reactive protein level with body mass index and severity of pre-eclampsia at third trimester.
Ertas IE; Kahyaoglu S; Yilmaz B; Ozel M; Sut N; Guven MA; Danisman N
J Obstet Gynaecol Res; 2010 Oct; 36(5):970-7. PubMed ID: 20722986
[TBL] [Abstract][Full Text] [Related]
20. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor.
Godoi LC; Gomes KB; Alpoim PN; Carvalho Md; Lwaleed BA; Sant'Ana Dusse LM
J Thromb Thrombolysis; 2012 Jul; 34(1):1-6. PubMed ID: 22461171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
